These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3050538)

  • 1. Application of flow cytometry and automated image analysis to the study of prostate cancer.
    Benson MC
    NCI Monogr; 1988; (7):25-9. PubMed ID: 3050538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry in carcinoma of the prostate.
    Benson MC; Ring K; Giella J
    Urol Clin North Am; 1990 Nov; 17(4):885-91. PubMed ID: 2219584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of impulse cytophotometry in the diagnosis and prognosis of prostate cancer].
    Zimmermann A; Truss F; Blech M; Schröter W; Barth M
    Urologe A; 1983 May; 22(3):151-6. PubMed ID: 6192580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Schröder F; Tribukait B; Böcking A; DeVere White R; Koss L; Lieber M; Stenkvist B; Zetterberg A
    Scand J Urol Nephrol Suppl; 1994; 162():51-63; discussion 15-27. PubMed ID: 7529429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A
    BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Digital image analysis in pathology--exemplified in prostatic cancer].
    Danielsen HE; Kildal W; Sudbø J
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):479-88. PubMed ID: 10833941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.
    Veltri RW; Partin AW; Epstein JE; Marley GM; Miller CM; Singer DS; Patton KP; Criley SR; Coffey DS
    J Cell Biochem Suppl; 1994; 19():249-58. PubMed ID: 7529856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus review of the clinical utility of DNA content cytometry in prostate cancer.
    Shankey TV; Kallioniemi OP; Koslowski JM; Lieber ML; Mayall BH; Miller G; Smith GJ
    Cytometry; 1993; 14(5):497-500. PubMed ID: 8354122
    [No Abstract]   [Full Text] [Related]  

  • 13. External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States.
    Hanks GE
    NCI Monogr; 1988; (7):75-84. PubMed ID: 3050542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in prostate cancer radiotherapy: consensus development.
    Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
    Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
    de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
    Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequent gene fusion in prostate cancer: clinical applications in diagnosis, prognosis and therapy].
    Schmidt F; Scheble V; Mertz K; Perner S; Rubin MA
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1483-6. PubMed ID: 19572250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis.
    Veltri RW; O'Dowd GJ; Orozco R; Miller MC
    Semin Urol Oncol; 1998 Aug; 16(3):106-17. PubMed ID: 9741414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An automated image cytometry system for monitoring DNA ploidy and other cell features of radiotherapy and chemotherapy patients.
    Zhang Y; LeRiche JC; Jackson SM; Garner D; Palcic B
    Radiat Med; 1999; 17(1):47-57. PubMed ID: 10378652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.